APPLICATION
ANDA070738
TYPE
ANDA
ORIGINAL APPROVAL
1987-05-06
LATEST ACTION
2021-12-20
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 5MG/2ML (2.5MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2021-12-20Labeling · Supplement 16 · standardAP
2021-12-20Labeling · Supplement 17 · standardAP
1998-12-09Manufacturing (CMC) · Supplement 8AP
1998-03-26Labeling · Supplement 4AP
1996-10-03Manufacturing (CMC) · Supplement 6AP
1991-04-17Labeling · Supplement 3AP
1990-05-17Manufacturing (CMC) · Supplement 1AP
1990-02-16Labeling · Supplement 2AP
1987-05-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.